Teva Executive and Leadership Team

Alexander Joramsa, the Chief Financial Officer (Asia Pacific, Japan) at Teva, directs all financial planning and analysis for the region. Joramsa oversees capital allocation and budgetary control to support the expansion of generic and innovative medicine distribution across diverse Asian markets. By managing regional fiscal health, the Chief Financial Officer (Asia Pacific, Japan) ensures that local operations remain profitable while adhering to global compliance standards. Alexander Joramsa evaluates investment opportunities and risk management strategies to bolster the company's market position in Japan and surrounding territories. This leadership role involves close coordination with global finance teams to maintain consistent reporting and operational efficiency. Through meticulous oversight of regional assets, Joramsa drives financial stability and supports the broader mission of increasing access to quality treatments. The Chief Financial Officer (Asia Pacific, Japan) provides the necessary fiscal guidance to navigate complex regulatory environments and competitive pressures in the region.

Efrat Yehudai, the Senior Vice President, Chief Financial Officer Teva Global Operations at Teva, manages the financial architecture of the company's manufacturing and supply chain network. Yehudai oversees cost optimization and capital investment for global production facilities to ensure the efficient delivery of medicines. By analyzing operational expenditures, the Senior Vice President, Chief Financial Officer Teva Global Operations identifies efficiencies that support the production of high-quality generics and biosimilars. Efrat Yehudai collaborates with global operations leadership to align financial performance with manufacturing output and quality standards. This role involves managing complex budgets across international sites to maintain the scalability of the supply chain. Through strategic financial oversight, Yehudai ensures that the company remains competitive in the global pharmaceutical market. The Senior Vice President, Chief Financial Officer Teva Global Operations provides the fiscal discipline required to sustain large-scale production while meeting the evolving needs of patients worldwide.

Eli Kalif, the Chief Financial Officer & Executive VP at Teva, directs the global financial strategy and corporate fiscal policy. Kalif oversees capital structure, investor relations, and financial reporting to ensure the long-term stability of the organization. By managing the company's balance sheet, the Chief Financial Officer & Executive VP supports the development and manufacturing of a broad portfolio of medicines. Eli Kalif collaborates with the Board and executive leadership to drive growth initiatives and optimize resource allocation across all business units. This leadership role involves navigating global economic conditions to maintain profitability and shareholder value. Through rigorous financial planning, Kalif ensures that the company possesses the necessary resources to advance scientific research and expand access to quality treatments. The Chief Financial Officer & Executive VP provides the strategic financial vision required to sustain the company's position as a global biopharmaceutical leader while addressing unmet patient needs.

Deborah Yu, the Chief Financial Officer, Teva Handok Pharma Co, Ltd at Teva, manages the financial operations for the joint venture. Yu oversees local accounting, tax compliance, and financial planning to ensure the successful distribution of pharmaceutical products in the specific market. By monitoring regional revenue streams, the Chief Financial Officer, Teva Handok Pharma Co, Ltd identifies opportunities to improve operational margins and support local growth. Deborah Yu coordinates with the broader corporate finance team to ensure alignment with global reporting standards and strategic objectives. This role involves managing local financial risks and optimizing the allocation of resources to support the delivery of innovative therapies. Through diligent fiscal oversight, Yu ensures that the joint venture remains a key contributor to the company's overall success. The Chief Financial Officer, Teva Handok Pharma Co, Ltd provides the financial leadership necessary to navigate the unique regulatory and market dynamics of the region.

Craig Olson, the Global Chief Financial Officer, Operations at Teva, directs the financial strategy for the company's worldwide operational footprint. Olson oversees the budgeting and performance analysis for manufacturing, logistics, and supply chain functions. By implementing financial controls, the Global Chief Financial Officer, Operations ensures that the production of generics and biosimilars remains cost-effective and scalable. Craig Olson collaborates with operational leaders to drive efficiency improvements and support the global delivery of medicines. This role involves managing capital expenditures for facilities and technology to maintain high standards of quality and compliance. Through strategic financial planning, Olson supports the company's mission to streamline the delivery of treatments to patients globally. The Global Chief Financial Officer, Operations provides the fiscal insights necessary to optimize the supply chain and ensure that the company meets its production targets while maintaining financial health across all international operations.

Luigi Tiravanti, the Director, Finance & Chief Financial Officer at Teva, manages the financial integrity and reporting for specific business segments. Tiravanti oversees internal audits, financial planning, and risk management to ensure compliance with corporate policies. By analyzing segment-specific performance, the Director, Finance & Chief Financial Officer identifies trends that impact the profitability of the pharmaceutical portfolio. Luigi Tiravanti coordinates with department heads to align financial goals with the company's broader mission of improving health outcomes. This role involves managing cash flow and optimizing working capital to support ongoing research and development efforts. Through effective financial leadership, Tiravanti ensures that the business unit operates with fiscal discipline and transparency. The Director, Finance & Chief Financial Officer provides the necessary financial guidance to support strategic decision-making and ensure that the company remains a leader in the delivery of quality medicines to patients.

Nishank Bhargava, the Regional Director, Finance & Chief Financial Officer (India) at Teva, directs all financial activities within the Indian market. Bhargava oversees local regulatory compliance, tax strategy, and financial planning to support the company's manufacturing and commercial presence. By managing regional fiscal operations, the Regional Director, Finance & Chief Financial Officer (India) ensures that the business remains profitable while expanding access to quality medicines. Nishank Bhargava collaborates with global finance teams to integrate regional performance data into the broader corporate strategy. This role involves navigating the complex economic landscape of India to optimize resource allocation and support local growth initiatives. Through diligent financial oversight, Bhargava ensures that the company maintains a strong competitive position in the region. The Regional Director, Finance & Chief Financial Officer (India) provides the fiscal leadership necessary to support the company's mission of addressing unmet patient needs through efficient and sustainable operations.

Alicia Logan, the Head of Commercial Excellence Chief of Staff (US) at Teva, drives strategic alignment across North American operations. Logan optimizes sales force effectiveness and market access strategies to ensure the broad portfolio of medicines reaches patients efficiently. By analyzing commercial data, the Head of Commercial Excellence Chief of Staff (US) identifies growth opportunities within the competitive pharmaceutical landscape. Alicia Logan coordinates cross-functional teams to streamline the delivery of pharmacy brands and innovative therapies. This leadership position involves refining go-to-market models and enhancing the impact of commercial initiatives. Through rigorous performance monitoring, Logan ensures that regional operations meet financial and patient-centric targets. The Head of Commercial Excellence Chief of Staff (US) maintains close collaboration with executive leadership to translate corporate vision into actionable regional plans. By fostering a culture of excellence, Logan supports the long-term sustainability of the business in the United States.

Guillermo Monroy, the LATAM Corporate Development Chief of Staff & Director (Mergers Acquisitions & Strategy) at Teva, architects growth strategies across Latin American markets. Monroy evaluates potential mergers and acquisitions to expand the company's footprint in complex generics and biosimilars. By leading strategic planning, the LATAM Corporate Development Chief of Staff & Director (Mergers Acquisitions & Strategy) identifies opportunities to enhance the regional portfolio and improve patient access to essential medicines. Guillermo Monroy coordinates with executive leadership to ensure that inorganic growth initiatives align with the global corporate mission. This role involves rigorous market analysis and the execution of high-stakes transactions that strengthen the competitive position of the firm. Through effective project management and strategic foresight, Monroy drives the integration of new assets into the existing operational framework. The LATAM Corporate Development Chief of Staff & Director (Mergers Acquisitions & Strategy) ensures that all regional development efforts contribute to long-term financial and operational success.

Judith Campbell, the Executive PA at Teva, manages complex scheduling and high-level communication workflows for senior leadership. Campbell coordinates critical meetings and ensures administrative efficiency across the global biopharmaceutical organization. By maintaining rigorous organizational standards, the Executive PA facilitates seamless collaboration between departments. Judith Campbell optimizes time management for the executive team, allowing focus on strategic initiatives related to generic medicine production and patient access. This role requires precise attention to detail and proactive problem-solving to support the broader mission of improving health outcomes. Through effective gatekeeping and information management, the Executive PA maintains the operational tempo necessary for a global leader in the pharmaceutical industry. Campbell provides essential support that enables the leadership team to execute complex business strategies across international markets, ensuring that all administrative functions align with the overarching goals of the company.